Message Font: Serif | Sans-Serif
No. of Recommendations: 0
Vanda Pharma looks an interesting situation.

The company's got the drug and looks to be getting the marketing under way.

The market is apparently not that big but pretty much their own.

It seems the drug should be profitable with mktg and BMY royalties the main expenses. I'd guess the mktg should decline over time as well.

Patent goes through 2017, with likely extension, they say, to 2022.

Ok, where's the booby trap and what's the downside?
Print the post  


When Life Gives You Lemons
We all have had hardships and made poor decisions. The important thing is how we respond and grow. Read the story of a Fool who started from nothing, and looks to gain everything.
Contact Us
Contact Customer Service and other Fool departments here.
Work for Fools?
Winner of the Washingtonian great places to work, and Glassdoor #1 Company to Work For 2015! Have access to all of TMF's online and email products for FREE, and be paid for your contributions to TMF! Click the link and start your Fool career.